ibalizumab-uiyk 200 MG per 1.33 ML Injection
- RxCUI
- 2043317
- RxNorm name
- ibalizumab-uiyk 200 MG per 1.33 ML Injection
- Display name
- ibalizumab-uiyk 200 MG per 1.33 ML Injection
- Full name
- ibalizumab-uiyk 200 MG per 1.33 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761065 | Trogarzo | ibalizumab-uiyk | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TROGARZO | IBALIZUMAB | Theratechnologies Inc. | c548ad82-9d1f-4d16-95b6-4e6106badf43 | 2026-01-07 | Warnings, Adverse reactions | 2043317 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c548ad82-9d1f-4d16-95b6-4e6106badf43 | ibalizumab-uiyk 200 MG per 1.33 ML Injection | SY | 13 | These highlights do not include all the information needed to use TROGARZO safely and effectively. See full prescribing information for TROGARZO. TROGARZO ® (ibalizumab-uiyk) injection, for intravenous use Initial U.S. Approval: 2018 | 20260107 |
| c548ad82-9d1f-4d16-95b6-4e6106badf43 | 1.33 ML ibalizumab-uiyk 150 MG/ML Injection | SCD | 13 | These highlights do not include all the information needed to use TROGARZO safely and effectively. See full prescribing information for TROGARZO. TROGARZO ® (ibalizumab-uiyk) injection, for intravenous use Initial U.S. Approval: 2018 | 20260107 |
| c548ad82-9d1f-4d16-95b6-4e6106badf43 | ibalizumab-uiyk 200 MG in 1.33 mL Injection | PSN | 13 | These highlights do not include all the information needed to use TROGARZO safely and effectively. See full prescribing information for TROGARZO. TROGARZO ® (ibalizumab-uiyk) injection, for intravenous use Initial U.S. Approval: 2018 | 20260107 |